Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

DANIEL R FIELD

Allopathic & Osteopathic Physicians Hospitalist

NPI
1922485531
CMS profile
2774621
Location
BISMARCK, ND

General Payments · PY2018–2024

$3,482.13

  • Reported across 287 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$254.56

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $254.56 14

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
DEXCOM, INC. $107.49 6
PFIZER INC. $42.11 2
Astellas Pharma US Inc $33.09 2
ABBVIE INC. $25.92 1
Lexicon Pharmaceuticals, Inc. $16.38 1
NOVARTIS PHARMACEUTICALS CORPORATION $16.14 1
Gilead Sciences, Inc. $13.43 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $360.86 30
PY2019 $1,888.86 180
PY2020 $239.60 17
PY2021 $186.45 13
PY2022 $188.97 12
PY2023 $362.83 21
PY2024 $254.56 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $25.92 10/22/2024 Food and Beverage Undisputed 01/23/2026 1103726448 CMS
Astellas Pharma US Inc $19.57 01/18/2024 Food and Beverage Undisputed 01/23/2026 1139312540 CMS
Astellas Pharma US Inc $13.52 03/22/2024 Food and Beverage Undisputed 01/23/2026 1139335220 CMS
Dexcom, Inc. $13.60 01/10/2024 Food and Beverage Undisputed 01/23/2026 1153294229 CMS
Dexcom, Inc. $17.91 04/10/2024 Food and Beverage Undisputed 01/23/2026 1153294231 CMS
Dexcom, Inc. $19.47 05/06/2024 Food and Beverage Undisputed 01/23/2026 1153294233 CMS
Dexcom, Inc. $18.55 06/10/2024 Food and Beverage Undisputed 01/23/2026 1153294237 CMS
Dexcom, Inc. $16.45 07/19/2024 Food and Beverage Undisputed 01/23/2026 1153294235 CMS
Dexcom, Inc. $21.51 09/06/2024 Food and Beverage Undisputed 01/23/2026 1153294239 CMS
Gilead Sciences, Inc. $13.43 11/14/2024 Food and Beverage Undisputed 01/23/2026 1133839190 CMS
Lexicon Pharmaceuticals, Inc. $16.38 05/07/2024 Food and Beverage Undisputed 01/23/2026 1081697995 CMS
Novartis Pharmaceuticals Corporation $16.14 04/12/2024 Food and Beverage Undisputed 01/23/2026 1086805463 CMS
PFIZER INC. $22.00 01/15/2024 Food and Beverage Undisputed 01/23/2026 1130964516 CMS
PFIZER INC. $20.11 09/24/2024 Food and Beverage Undisputed 01/23/2026 1131998639 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.